Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 202(5): 1549-1558, 2019 03 01.
Article in English | MEDLINE | ID: mdl-30665935

ABSTRACT

Superoxide anion production by the phagocyte NADPH oxidase plays a crucial role in host defenses and inflammatory reaction. The phagocyte NADPH oxidase is composed of cytosolic components (p40phox, p47phox, p67phox, and Rac1/2) and the membrane flavocytochrome b558, which is composed of two proteins: p22phox and gp91phox/NOX2. p22phox plays a crucial role in the stabilization of gp91phox in phagocytes and is also a docking site for p47phox during activation. In the current study, we have used a yeast two-hybrid approach to identify unknown partners of p22phox. Using the cytosolic C-terminal region of p22phox as bait to screen a human spleen cDNA library, we identified the protein interacting with amyloid precursor protein tail 1 (PAT1) as a potential partner of p22phox. The interaction between p22phox and PAT1 was further confirmed by in vitro GST pulldown and overlay assays and in intact neutrophils and COSphox cells by coimmunoprecipitation. We demonstrated that PAT1 is expressed in human neutrophils and monocytes and colocalizes with p22phox, as shown by confocal microscopy. Overexpression of PAT1 in human monocytes and in COSphox cells increased superoxide anion production and depletion of PAT1 by specific small interfering RNA inhibited this process. These data clearly identify PAT1 as a novel regulator of NADPH oxidase activation and superoxide anion production, a key phagocyte function.


Subject(s)
Amino Acid Transport Systems/metabolism , Phagocytes/metabolism , Superoxides/metabolism , Symporters/metabolism , Amino Acid Transport Systems/genetics , Anions/metabolism , Humans , RNA, Messenger/genetics , RNA, Messenger/metabolism , Symporters/genetics
2.
Oxid Med Cell Longev ; 2016: 9346242, 2016.
Article in English | MEDLINE | ID: mdl-27528888

ABSTRACT

In pathological situations such as ischemia-reperfusion and acute respiratory distress syndrome, reactive oxygen species (ROS) are produced by different systems which are involved in endothelial cells injury, ultimately leading to severe organ dysfunctions. The aim of this work was to study the effect of ROS produced by hypoxanthine-xanthine oxidase (Hx-XO) on the adhesion of human umbilical vein endothelial cells (HUVEC) and on the signaling pathways involved. Results show that Hx-XO-derived ROS induced an increase in HUVEC adhesion in the early stages of the process (less than 30 min), followed by a decrease in adhesion in the later stages of the process. Interestingly, Hx-XO-derived ROS induced the same biphasic effect on the phosphorylation of the focal adhesion kinase (FAK), a nonreceptor tyrosine kinase critical for cell adhesion, but not on ERK1/2 phosphorylation. The biphasic effect was not seen with ERK1/2 where a decrease in phosphorylation only was observed. Wortmannin, a PI3-kinase inhibitor, inhibited ROS-induced cell adhesion and FAK phosphorylation. Orthovanadate, a protein tyrosine phosphatase inhibitor, and Resveratrol (Resv), an antioxidant agent, protected FAK and ERK1/2 from dephosphorylation and HUVEC from ROS-induced loss of adhesion. This study shows that ROS could have both stimulatory and inhibitory effects on HUVEC adhesion and FAK phosphorylation and suggests that PI3-kinase and tyrosine phosphatase control these effects.


Subject(s)
Cell Adhesion/drug effects , Focal Adhesion Protein-Tyrosine Kinases/metabolism , Reactive Oxygen Species/metabolism , Xanthine Oxidase/pharmacology , Androstadienes/pharmacology , Human Umbilical Vein Endothelial Cells , Humans , Hypoxanthine/pharmacology , Immunoprecipitation , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation/drug effects , Resveratrol , Stilbenes/pharmacology , Wortmannin , Xanthine Oxidase/genetics , Xanthine Oxidase/metabolism
3.
Mol Cell Biol ; 24(24): 10703-17, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15572675

ABSTRACT

The mechanisms involved in the cytotoxic action of oxysterols in the pathogenesis of atherosclerosis still remain poorly understood. Among the major oxysterols present in oxidized low-density lipoprotein, we show here that 7-ketocholesterol (7-Kchol) induces oxidative stress and/or apoptotic events in human aortic smooth muscle cells (SMCs). This specific effect of 7-Kchol is mediated by a robust upregulation (threefold from the basal level) of Nox-4, a reactive oxygen species (ROS)-generating NAD(P)H oxidase homologue. This effect was highlighted by silencing Nox-4 expression with a specific small interfering RNA, which significantly reduced the 7-Kchol-induced production of ROS and abolished apoptotic events. Furthermore, the 7-Kchol activating pathway included an early triggering of endoplasmic reticulum stress, as assessed by transient intracellular Ca(2+) oscillations, and the induction of the expression of the cell death effector CHOP and of GRP78/Bip chaperone via the activation of IRE-1, all hallmarks of the unfolded protein response (UPR). We also showed that 7-Kchol activated the IRE-1/Jun-NH(2)-terminal kinase (JNK)/AP-1 signaling pathway to promote Nox-4 expression. Silencing of IRE-1 and JNK inhibition downregulated Nox-4 expression and subsequently prevented the UPR-dependent cell death induced by 7-Kchol. These findings demonstrate that Nox-4 plays a key role in 7-Kchol-induced SMC death, which is consistent with the hypothesis that Nox-4/oxysterols are involved in the pathogenesis of atherosclerosis.


Subject(s)
Apoptosis/drug effects , Endoplasmic Reticulum/physiology , Gene Expression Regulation, Enzymologic , Ketocholesterols/pharmacology , Muscle, Smooth/drug effects , NADPH Oxidases/metabolism , Aorta/cytology , CCAAT-Enhancer-Binding Proteins/metabolism , Calcium/analysis , Calcium/metabolism , Cells, Cultured , Endoplasmic Reticulum Chaperone BiP , Endothelium, Vascular/cytology , Fluorescent Antibody Technique, Indirect , Genes, Reporter , Heat-Shock Proteins/metabolism , Humans , Iron Regulatory Protein 1/metabolism , JNK Mitogen-Activated Protein Kinases/metabolism , Ketocholesterols/metabolism , Kinetics , Luciferases/metabolism , Microscopy, Fluorescence , Molecular Chaperones/metabolism , Molecular Sequence Data , NADPH Oxidase 4 , Oxidative Stress , Protein Denaturation , RNA, Messenger/metabolism , RNA, Small Interfering/metabolism , Reactive Oxygen Species/analysis , Reactive Oxygen Species/metabolism , Signal Transduction , Transcription Factor CHOP , Transcription Factors/metabolism
4.
Biochem Pharmacol ; 68(10): 2003-8, 2004 Nov 15.
Article in English | MEDLINE | ID: mdl-15476671

ABSTRACT

Hydroxytyrosol (HT) (also known as dihydroxyphenylethanol (DPE)) is a polyphenol extracted from virgin olive oil. HT is known to exert an antioxidant effect but the mechanism of action and the identity of the reactive oxygen molecule(s) targeted are not known. In this study, we show that HT inhibits luminol-amplified chemiluminescence of human neutrophils stimulated with N-formyl-methionyl-leucyl-phenylalanine (fMLP), phorbol myristate acetate (PMA) and opsonized zymosan. This effect was dose-dependent and occurred immediately after the addition of HT. However, HT had no effect on lucigenin-amplified chemiluminescence, suggesting that it does not inhibit NADPH oxidase activation or scavenge superoxide anions. Furthermore, HT inhibited H(2)O(2)-dependent-dichlorofuoroscein (DCFH) fluorescence of activated neutrophils, as measured by flow cytometry. Finally, HT inhibited luminol-amplified chemiluminescence in a cell-free system consisting of H(2)O(2) and HRPO. These results suggest that HT, a polyphenol derived from olive oil, could exert its antioxidant effect by scavenging hydrogen peroxide but not superoxide anion released during the respiratory burst.


Subject(s)
Free Radical Scavengers/pharmacology , Hydrogen Peroxide/metabolism , Neutrophils/metabolism , Phenylethyl Alcohol/analogs & derivatives , Phenylethyl Alcohol/pharmacology , Plant Oils/chemistry , Superoxides/metabolism , Acridines/pharmacology , Adult , Flavonoids/pharmacology , Flow Cytometry , Fluoresceins/pharmacology , Horseradish Peroxidase/metabolism , Humans , Luminescent Measurements , Luminol/pharmacology , Olive Oil , Phenols/pharmacology , Polyphenols
5.
Biochem Pharmacol ; 67(1): 183-90, 2004 Jan 01.
Article in English | MEDLINE | ID: mdl-14667941

ABSTRACT

The polymorphonuclear neutrophil (PMN)-respiratory burst plays a key role in host defense and inflammatory reactions. Modulation of this key neutrophil function by endogenous agents and the mechanisms involved are poorly understood. This study was designed to analyze the mechanisms involved in the effect of adrenaline on neutrophil superoxide anions production. Using the superoxide dismutase (SOD)-inhibitable cytochrome c reduction assay, we report here that the beta-adrenergic agonist, adrenaline at physiologic concentrations (5-100 nM) inhibited formyl-methionyl-leucyl-phenylalanine (fMLP)-stimulated but not phorbol-myristate-acetate (PMA)-stimulated PMN superoxide anion production. The inhibitory effect of adrenaline runs in parallel with an increase in intracellular levels of cAMP which was reversed by the protein kinase A (PKA) inhibitor H-89, suggesting a role for PKA in mediating the inhibitory effect of adrenaline on fMLP-induced superoxide production. Adrenaline at physiological concentrations did not inhibit the fMLP-stimulated membrane translocation of the NADPH oxidase components p47phox and p67phox, nor the fMLP-stimulated phosphorylation of p47phox. However, adrenaline strongly depressed the activity of the cytosolic isoform of Phospholipase A(2) (cPLA(2)). We suggest that adrenaline inhibits fMLP induced superoxide production upstream of the NADPH oxidase via a mechanism involving PKA and cPLA(2).


Subject(s)
Epinephrine/pharmacology , N-Formylmethionine Leucyl-Phenylalanine/antagonists & inhibitors , Neutrophils/drug effects , Phospholipases A/metabolism , Phosphoproteins/metabolism , Respiratory Burst/drug effects , Sulfonamides , Biological Transport , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Cyclic AMP-Dependent Protein Kinases/metabolism , Eicosanoic Acids/pharmacology , Humans , Isoquinolines/pharmacology , NADPH Oxidases , Neutrophils/enzymology , Neutrophils/metabolism , Phospholipases A2 , Phosphorylation/drug effects , Respiratory Burst/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...